4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-054075
Director sold 52,037 shares at an average $16.57 ($862,109)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SCHIFF ANDREW N Director | 2022-10-17 | Sale | −19,944 | $16.05 | $320,087 | 561,648 | I |
| SCHIFF ANDREW N Director | 2022-10-18 | Sale | −32,093 | $16.89 | $542,022 | 529,555 | I |
| Open-market sales · 52,037 sh · avg $16.57 · $862,109 | |||||||
Loading xslF345X03/doc4.xml…